Trial intelligence / Profile preview

Estrogen vs Trimo-San in postmenopausal pessary users

NCT03943823Phase 4Terminated

Sponsor
UTHealth Houston
Start
May 2019
Primary completion
Mar 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial in bacterial vaginosis (BV) and vaginal discharge comparing Estrogen vaginal cream with Trimo-San vaginal gel (2 arms). Primary endpoint: Vaginal pH as Measured by pH Strips at 3 months. Started May 2019; status: terminated.

02

Drugs

Estrogen vaginal creamhydroxyquinolone
03

Conditions

bacterial vaginosis (BV)vaginal discharge

Beyond the preview

Go deeper on NCT03943823.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03943823.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call